Depression, Anxiety, IBS - Irritable Bowel Syndrome
Conditions
Keywords
Depression, Anxiety, Irritable bowel syndrome, Viome precision nutrition program, VNPN, IBS, PHQ9, GAD7, ROME-IV, Viome, Diet, Nutrition, Supplements
Brief summary
Viome costumers are consented and recruited for this study and complete the questionnaires upon enrollment. Any participant who previously self reported depression, anxiety, or Irritable Bowel Syndrome (IBS) qualify for this study. All participants receive Viome's diet, supplement and recommendations.
Detailed description
Participants receive Viome Precision Nutrition Program (VPNP) after completing the health assessment and questionnaire. VPNP consists of diet, supplement and recommendations based on results from their sample results and their self reported questionnaire. After approximately 5 months, participants were given the same health assessment questionnaire. The results and data collected before and after the VPNP are analyzed to find correlations and differences between the measurements taken at the beginning of the trial and again approximately 5 months after.
Interventions
DIETARY_SUPPLEMENTVIOME Precision Nutrition Program
Diet and supplements recommendations
Sponsors
Viome
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
This is a single group cohort study; the first cohort consists of participants with self reported Irritable Bowel Syndrome (IBS), the second cohort consists of participants with self reported depression and the last cohort consists of participants with self reported anxiety. All cohorts receive diet and supplement recommendations from Viome based on participants' sample results.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* PHQ-9 score 5 or above * GAD-7 score 5 or above * IBS ROME-IV score 125 or above * Females and males aged 18 years or older * Signed and dated informed consent prior to any trial-specific procedures are performed * Able to speak and read English * Willing and able to follow the trial instructions * Viome existing costumer
Exclusion criteria
* Unable/unwilling to complete the provided questionnaires
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Disease activity changes for IBS | ~5 months | Change of disease activity measurements in participants with self reported IBS after they have received Viome Precision Nutrition Program (VPNP), which consists of dietary supplement recommendations from Viome using clinically validated questionnaires. For IBS, Rome IV classification and criteria based on interpretation and self reporting of IBS, experience and symptoms were used to measure before and after VPNP for approximate duration of 5 months. |
| Disease activity changes depression | ~5 months | Change of disease activity measurements in participants with self reported depression after they have received Viome Precision Nutrition Program (VPNP), which consists of dietary supplement recommendations from Viome using clinically validated questionnaires. For depression, brief patient health questionnaire mood scale (PHQ-9) was used. |
| Disease activity changes anxiety | ~5 months | Change of disease activity measurements in participants with self reported anxiety after they have received Viome Precision Nutrition Program (VPNP), which consists of dietary supplement recommendations from Viome using clinically validated questionnaires. For anxiety, General Anxiety Disorder 7 (GAD-7) was used, which is designed to assess the participants' health status during the previous 2 weeks. |
Countries
United States
Outcome results
None listed